Key result
PFO closure resolves cough-induced syncope with sustained symptom freedom over ~3 years.
Why the study?
Patent foramen ovale is a rare etiology of cough-induced syncope, and diagnostic and therapeutic strategies are needed when transesophageal echocardiography is contraindicated.
Case Report (n=1)
No
This case report highlights patent foramen ovale with right-to-left shunting as a rare cause of cough-induced syncope that can be diagnosed with contrast transthoracic echocardiography when transesophageal echocardiography is contraindicated and effectively treated with percutaneous PFO closure.
Answers are grounded in this paper and cite their sources.
May support PFO closure consideration in select cirrhosis cough syncope cases; leaves open confirmation in prospective trials.
This case report describes a 48-year-old male with liver cirrhosis presenting with recurrent cough-induced syncope over one month. Each episode of coughing was immediately followed by dizziness, loss of consciousness, and witnessed convulsions lasting seconds. Brain imaging revealed ischemic white matter lesions (modified Fazekas grade 1),whereas chest CT suggested portal hypertension (splenomegaly, esophagogastric varices). Transthoracic echocardiography with agitated saline contrast (cTTE) demonstrated a large right-to-left shunt. Transesophageal echocardiography (TEE) was contraindicated due to varices. A diagnosis of patent foramen ovale (PFO)-mediated paradoxical embolism triggered by Valsalva-like cough was hypothesized. During percutaneous PFO closure, catheter passage through the PFO provoked dizziness, and a subsequent cough instantly reproduced syncope with convulsions. A 25-mm Amplatzer™ PFO Occluder was successfully implanted. Post-procedure, cough-induced syncope ceased within one month. Six-month follow-up cTTE confirmed complete shunt closure, and the patient remained free of seizures and syncope throughout three years of follow-up. This case underscores PFO may be as a critical etiology for cough syncope and demonstrates diagnostic and therapeutic strategies when TEE is not feasible.
No takes yet. Share an insight, caveat, or question.
He et al. (2026) conducted a case report in Cough-induced syncope due to patent foramen ovale (PFO) with right-to-left shunt (n=1). Percutaneous PFO closure using a 25-mm Amplatzer PFO Occluder was evaluated on Resolution of cough-induced syncope and complete right-to-left shunt closure. Percutaneous PFO closure with a 25-mm occluder resolved cough-induced syncope within 1 month, with complete shunt closure at 6 months and freedom from syncope over 3 years.
Synapse has enriched 10 related papers. Consider them for comparative context: